Leo Pharma As Drug Patent Portfolio
Leo Pharma As owns 6 orange book drugs protected by 26 US patents with Desonate having the least patent protection, holding only 1 patent. And Enstilar with maximum patent protection, holding 11 patents. Given below is the list of Leo Pharma As's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Dec, 2031 | Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Dec, 2031 | Active |
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10617698 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10660908 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10682364 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10688108 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US10716799 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9566286 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | 10 Jun, 2031 | Active |
| US9211259 | Antibiotic kit and composition and uses thereof | 28 Feb, 2029 | Active |
| US9265725 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof | 08 Dec, 2027 | Active |
| US10117812 | Foamable composition combining a polar solvent and a hydrophobic carrier | 18 Oct, 2027 | Active |
| US7700076 | Penetrating pharmaceutical foam | 18 Sep, 2027 | Active |
| US8435498 | Penetrating pharmaceutical foam | 01 Mar, 2024 | Expired |
| US10322085 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof | 24 Oct, 2023 | Expired |
| US8722021 | Foamable carriers | 24 Oct, 2023 | Expired |
| US8900554 | Foamable composition and uses thereof | 24 Oct, 2023 | Expired |
| US6387383 | Topical low-viscosity gel composition | 03 Aug, 2020 | Expired |
| US6753013 | Pharmaceutical composition | 27 Jan, 2020 | Expired |
| US6787529 | Topical composition | 27 Jan, 2020 | Expired |
| US6730288 | Mousse composition | 08 Sep, 2019 | Expired |
| US6534070 | Composition with azelaic acid | 18 Nov, 2018 | Expired |
| US5763426 | Crystalline form of a vitamin D analogue | 09 Jun, 2015 | Expired |
| USRE39706 | Crystalline form of a vitamin D analogue | 09 Jun, 2015 | Expired |
| US5665727 | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them | 09 Sep, 2014 | Expired |
Latest Legal Activities on Leo Pharma As's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Leo Pharma As.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Jul, 2024 | US9566286 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 Nov, 2023 | US10716799 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 31 Oct, 2023 | US10688108 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Oct, 2023 | US10682364 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Oct, 2023 | US10660908 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 16 Aug, 2023 | US10617698 |
| Post Issue Communication - Certificate of Correction | 03 Jan, 2023 | US10682364 |
| Post Issue Communication - Certificate of Correction | 03 Jan, 2023 | US10617698 |
| Post Issue Communication - Certificate of Correction | 03 Jan, 2023 | US10660908 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Jan, 2023 | US9119781 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Dec, 2022 | US10322085 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 May, 2022 | US10130640 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 27 Apr, 2022 | US10117812 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 Nov, 2021 | US8722021 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Oct, 2021 | US7700076 |
Leo Pharma As Drug Patents' Oppositions Filed in EPO
Leo Pharma As drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Dec 29, 2014, by Guderma Gmbh. This opposition was filed on patent number EP03772600A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP11726055A | Sep, 2015 | Pentafarma Sociedade Técnico-Medicinal S.A. | Opposition rejected |
| EP03772600A | Sep, 2015 | Henkel AG & Co. KGaA | Patent maintained as amended |
| EP03772600A | Dec, 2014 | Guderma GmbH | Patent maintained as amended |
Leo Pharma As's Family Patents
Leo Pharma As Drug List
Given below is the complete list of Leo Pharma As's drugs and the patents protecting them.
1. Desonate
Desonate is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6387383 | Topical low-viscosity gel composition |
03 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Desonate's drug page
2. Dovonex
Dovonex is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763426 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(9 years ago)
| Expired |
| USRE39706 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dovonex's drug page
3. Enstilar
Enstilar is protected by 11 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130640
(Pediatric)
| Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Dec, 2031
(6 years from now)
| Active |
| US9119781
(Pediatric)
| Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Dec, 2031
(6 years from now)
| Active |
| US10130640 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US10617698 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US10660908 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US10682364 | Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US10688108 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US10716799 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US9119781 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US9566286 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
10 Jun, 2031
(6 years from now)
| Active |
| US6753013 | Pharmaceutical composition |
27 Jan, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Enstilar's drug page
4. Finacea
Finacea is protected by 10 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9211259 | Antibiotic kit and composition and uses thereof |
28 Feb, 2029
(3 years from now)
| Active |
| US9265725 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
08 Dec, 2027
(2 years from now)
| Active |
| US10117812 | Foamable composition combining a polar solvent and a hydrophobic carrier |
18 Oct, 2027
(2 years from now)
| Active |
| US7700076 | Penetrating pharmaceutical foam |
18 Sep, 2027
(2 years from now)
| Active |
| US8435498 | Penetrating pharmaceutical foam |
01 Mar, 2024
(1 year, 2 months ago)
| Expired |
| US10322085 | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
24 Oct, 2023
(1 year, 6 months ago)
| Expired |
| US8722021 | Foamable carriers |
24 Oct, 2023
(1 year, 6 months ago)
| Expired |
| US8900554 | Foamable composition and uses thereof |
24 Oct, 2023
(1 year, 6 months ago)
| Expired |
| US6730288 | Mousse composition |
08 Sep, 2019
(5 years ago)
| Expired |
| US6534070 | Composition with azelaic acid |
18 Nov, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Finacea's drug page
5. Protopic
Protopic is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5665727 | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them |
09 Sep, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Protopic's drug page
Explore Our Curated Drug Screens
6. Taclonex
Taclonex is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6753013 | Pharmaceutical composition |
27 Jan, 2020
(5 years ago)
| Expired |
| US6787529 | Topical composition |
27 Jan, 2020
(5 years ago)
| Expired |
| US5763426 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(9 years ago)
| Expired |
| USRE39706 | Crystalline form of a vitamin D analogue |
09 Jun, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Taclonex's drug page